Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Burcon NutraScience Corp (BRCNF) had Revenue of $0.27M for the most recently reported fiscal year, ending 2025-03-31.

Quarterly Annual

Figures for fiscal year ending 2025-03-31

Income Statement Financials
Revenue	$0.27M
Net Income	$-5.94M
Cost of Goods Sold	$0.90M
Gross Profit	$-0.63M
Operating Expenses	$5.81M
Operating Income	$-5.53M
Non-Operating Income/Expense	$-0.41M
Pre-Tax Income	$-5.94M
Normalized Pre-Tax Income	$-5.94M
Income after Taxes	$-5.94M
Income from Continuous Operations	$-5.94M
Consolidated Net Income/Loss	$-5.94M
Normalized Income after Taxes	$-5.94M
EBIT	$-5.53M
EBITDA	$0.46M
Weighted-Average Shares Outstanding (Basic)	7.82M
Weighted-Average Shares Outstanding (Diluted)	7.82M
Earnings per Share (EPS) (Basic)	$-0.76
Earnings per Share (EPS) (Diluted)	$-0.76
Balance Sheet Financials
Current Assets	$5.61M
Property, Plant, and Equipment	$0.69M
Long-Term Assets	$16.43M
Total Assets	$22.03M
Current Liabilities	$3.09M
Long-Term Debt	$13.96M
Long-Term Liabilities	$13.96M
Total Liabilities	$17.04M
Common Equity	$4.99M
Tangible Shareholders Equity	$4.09M
Shareholders Equity	$4.99M
Common Shares Outstanding	12.69M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-39.62M
Cash Flow from Investing Activities	$-11.92M
Cash Flow from Financial Activities	$73.49M
Beginning Cash	$30.16M
End Cash	$52.29M
Increase/Decrease in Cash	$22.13M
Stock-Based Compensation	$5.36M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.82
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.74
Debt to Equity Ratio	3.23
Gross Margin	-228.31%
Operating Margin	-2018.75%
EBIT Margin	-2018.75%
EBITDA Margin	169.12%
Pre-Tax Profit Margin	-2166.98%
Profit Margin	-2166.98%
Free Cash Flow	$-41.80M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.01
Inventory Turnover	6.23
Receiveable Turnover	2.89
Days Sales in Receivables	126.30
Return on Equity	-119.03%
Return on Tangible Equity	-145.28%
Return on Assets	-26.96%
Return on Investments	-31.35%
Book Value Per Share	$0.39
Free Cash Flow per Share	$-5.35
Operating Cash Flow per Share	$-5.07

Data from Zacks Investment Research, Inc.